1. Home
  2. PEPG vs MLSS Comparison

PEPG vs MLSS Comparison

Compare PEPG & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEPG
  • MLSS
  • Stock Information
  • Founded
  • PEPG 2018
  • MLSS 1989
  • Country
  • PEPG United States
  • MLSS United States
  • Employees
  • PEPG N/A
  • MLSS N/A
  • Industry
  • PEPG Biotechnology: Pharmaceutical Preparations
  • MLSS Industrial Specialties
  • Sector
  • PEPG Health Care
  • MLSS Health Care
  • Exchange
  • PEPG Nasdaq
  • MLSS Nasdaq
  • Market Cap
  • PEPG 45.9M
  • MLSS 42.4M
  • IPO Year
  • PEPG 2022
  • MLSS 1995
  • Fundamental
  • Price
  • PEPG $1.87
  • MLSS $0.55
  • Analyst Decision
  • PEPG Buy
  • MLSS Buy
  • Analyst Count
  • PEPG 4
  • MLSS 1
  • Target Price
  • PEPG $7.25
  • MLSS $1.25
  • AVG Volume (30 Days)
  • PEPG 539.9K
  • MLSS 58.0K
  • Earning Date
  • PEPG 11-06-2025
  • MLSS 11-13-2025
  • Dividend Yield
  • PEPG N/A
  • MLSS N/A
  • EPS Growth
  • PEPG N/A
  • MLSS N/A
  • EPS
  • PEPG N/A
  • MLSS N/A
  • Revenue
  • PEPG N/A
  • MLSS $9,083,205.00
  • Revenue This Year
  • PEPG N/A
  • MLSS $17.24
  • Revenue Next Year
  • PEPG N/A
  • MLSS $14.58
  • P/E Ratio
  • PEPG N/A
  • MLSS N/A
  • Revenue Growth
  • PEPG N/A
  • MLSS 7.84
  • 52 Week Low
  • PEPG $0.88
  • MLSS $0.38
  • 52 Week High
  • PEPG $10.06
  • MLSS $1.39
  • Technical
  • Relative Strength Index (RSI)
  • PEPG 71.39
  • MLSS 39.70
  • Support Level
  • PEPG $1.35
  • MLSS $0.55
  • Resistance Level
  • PEPG $2.10
  • MLSS $0.65
  • Average True Range (ATR)
  • PEPG 0.17
  • MLSS 0.04
  • MACD
  • PEPG 0.06
  • MLSS -0.00
  • Stochastic Oscillator
  • PEPG 76.29
  • MLSS 0.90

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.

Share on Social Networks: